Stock Price
14.56
Daily Change
0.28 1.96%
Monthly
13.84%
Yearly
-3.96%
Q1 Forecast
13.43

Anika Therapeutics reported $0.13 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
Abbott USD 1.5 0.2 Dec/2025
Agenus USD -0.3 0.84 Dec/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Integra LifeSciences USD 0.83 0.29 Dec/2025
Intrexon USD -0.1 0.03 Jun/2024
J&J USD 2.46 0.34 Dec/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
MacroGenics USD -0.22 0.49 Dec/2025
Merit Medical Systems USD 1.04 0.12 Dec/2025
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 1.53 1.38 Dec/2025
Smith & Nephew USD 0.59 0.27 Dec/2025
Stryker USD 4.47 1.28 Dec/2025
Surmodics USD -0.25 0.28 Sep/2024
Veracyte USD 0.53 0.02 Dec/2025
Xencor USD -0.09 0.01 Dec/2025
Zimmer Biomet Holdings USD 2.42 0.52 Dec/2025